Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results
Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102, demonstrating potent antitumor...
Search results for "immuno-oncology drug"
Expanded Health Insurance Coverage Lowers Barrier to Care for Rare Heart and Kidney Disorder
Patients suffering from light-chain amyloidosis, a rare and debilitating blood disorder that causes abnormal proteins to accumulate in vital organs,...
A Single Cancer Shot: Local Injection Triggers Systemic Tumor Disappearance
For decades, one immuno-oncology strategy has held immense promise while repeatedly falling short: the use of CD40...
Huwons Lab SC Formulation Change Platform, Will It Succeed in the Market?
Huwons Global's subsidiary Huwons Lab is challenging the formulation change platform business that converts intravenous...
Korean Biotech Firms Join Forces to Uncover the Hidden Profiles of Cancer Cells
Even within a single tumor, cancer cells present many different "faces." While they may appear as a uniform mass, every...
Alteogen Poised for Surge in Milestone Revenue as Keytruda Qlex and Biosimilars Gain Momentum
Alteogen is set to accelerate its financial growth this year, driven by a surge in milestone payments and royalty...
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval
South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with...
Pharmaceutical Industry Establishes Successive R&BD Subsidiaries... Is Yuhan Corporation Joining?
Yuhan Corporation recently announced plans to establish a specialized subsidiary for 'Research and Business Development...
Dr. Han Jin-hwan, Formerly of Merck (MSD), Appointed Head of New Drug Research Institute at Ligand Pharmaceuticals
Ligand Pharmaceuticals announced on the 5th that it has recruited Dr. Han Jin-hwan, formerly of Merck, as the head of...